REVIEW ARTICLES
LECTURES
ORIGINAL ARTICLE
The aim of the study is to evaluate the efficacy of complex therapy of secondary osteoarthritis in patients with rheumatoid arthritis with the use of inhibitor of interleukin-1, including the dynamics of inflammatory markers.
Materials and methods: 248 patients with secondary osteoarthritis in rheumatoid arthritis were involved in the trial. The participants were divided into 4 groups: patients of group I took inhibitor of interleukin-1 (diacerein) in combination with laser therapy and methotrexate; inhibitor of interleukin-1 in complex with methotrexate took patients from group II; group 3 — laser therapy + methotrexate and patients of group IV took only methotrexate. The efficacy of therapy we estimated in 6 months.
Results: The constructed model surfaces indicated the decreased levels of IL-1, COMP and DAS 28 in group 1 till 6,68±0,37 pg/ml (p<0,001), 16,92±0,8 ng/ml х 10² (p<0,001) и 2,06±1,19 (p<0,05) accordingly in comparison with groups III and IV. Also the model surfaces revealed the interdependency of all these indicators. The control group (IV) reacted to the treatment by decreasing the indicators as well. However, the dynamics of the changes was significantly less. In patients of groups I and II the levels of ESR and CRP decreased to 13,95±0,52* (*p<0,001) and 10,97±0,43* (*p<0,001); 16,53±0,63* (*p<0,001) and 12,81±0,77* (*p<0,001) accordingly.
Conclusions: In comparison analysis we noted statistical significant advantages (p<0,01) of the use of diacerein with methotrexate regarding the dynamic of IL-1 and COMP, ESR, CRP in patient’s serum, which is accompanied by the reduction of basic disease activity on DAS 28.
Purpose of the study. To study lipid metabolism in chronic hepatitis C and to assess its impact on the formation of insulin resistance, steatosis and progression of liver fibrosis.
Materials and methods. The study included 205 patients with chronic hepatitis C (CHC). Conducts research, depending on the genotype C, viral load and body mass index (BMI) of the patients.
Results. CHC patients revealed a combined hyperlipoproteinemia on the background of op-pression synthesis of apolipoproteins A1 and B. Formation of hepatic steatosis was associated with HCV genotype 3 virus-induced viral load at ≥ 6 log10 IU/ml and metabolic in VL < 6 log10 IU/ml. In patients with chronic hepatitis C genotype 1, high viral load leads to inhibition of protein synthesis conveyor ApoA1 and increased synthesis of cholesterol, accompanied by abdominal obesity and the formation of insulin resistance. CHC patients with BMI < 25 kg/m2 viral load ≥ 6 log10 ME/ml was associated with dyslipidemia IV type on D. Fredriskson (1970), hyperglycemia, insulin resistance and diabetes. The advanced stage of liver fi brosis (F ≥ 3 on a scale METAVIR) and non-response to treatment were associated with a decrease in HDL cholesterol below normal. With an increase in viral load > 5 log10 ME/ml signifi cantly increased the risk of lipid and carbohydrate metabolism.
ANALYSIS OF CLINICAL CASES
ЮБИЛЕИ
ОБЩЕЕ ДЕЛО
We give a case report of idiopathic pulmonary arterial hypertension (PAH) in a male patient with cancer of kidney. The hypothesis of pathogenetic link between these diseases was made. The cause of pulmonary hypertension could be cancer with ectopic production of biologic active substances, growth factors in combination with the susceptibility to develop PAH in poor gene penetrance.
СИМПТОМАТОЛОГИЯ И ДИАГНОСТИКА
The article is devoted to the up-to-date data of the drug-induced liver diseases (DILD) problem and series of the clinical monitoring accomplished by the author. It contains the DILD risk factors, the main mechanisms and the clinical variants of the liver injuries and the main DILD diagnostics and treatment principles.
Type 2 diabetes is one of the most important social diseases. Improving the quality of life for patients with diabetes is one of the expected outcomes of the implementation of programs designed to optimize the organization of diabetes care to patients with type 2 diabetes mellitus. Evaluation of its effectiveness is carried out based on population and quality of life. Quality of life in patients is largely dependent on the patient’s place of residence (urban or rural). This article presents data on the quality of life of patients with type 2 diabetes according to sex and age living in rural areas.
ОТЧЕТ О МЕРОПРИЯТИИ
ISSN 2411-6564 (Online)